Study | Reason for exclusion |
---|---|
Barnes 2010 | These studies cover phase I (2‐week dose selection) and III (comparison arm changing from placebo to tiotropium/indacaterol during treatment period) of the Donohue 2010 trial, or did not report data with tiotropium |
Chapman 2010 | Cross‐over study design |
Di Marco 2006 | Single dose of treatment only |
Donohue 2011 | Cross‐over study design |
Golubev 2006 | Cross‐over study design |
Gross 2003 | Study duration ‐ 4 weeks |
Meyer 2008 | Cross‐over study design |
Meyer 2011 | Study duration ‐ 2 weeks |
Reisner 2011 | Cross‐over study design; study duration ‐ 1 week |
Rossi 2012 | Cross‐over study design |
Tashkin 2009 | Study duration ‐ 2 weeks |
ten Hacken 2007 | Cross‐over study design |
van der Vaart 2011 | Cross‐over study design |
van Noord 2003 | Cross‐over study design |
van Noord 2005 | Cross‐over study design |
van Noord 2006 | Cross‐over study design |
Vogelmeier 2010 | Cross‐over study design |